Thus, treatment with TGF-β1 PI polyamide might be effective in improving the injury caused by diabetes mellitus by suppressing podocyte injury via improvement of EndMT, as well as the crosstalk between glomerular endothelial cells and podocytes that occur with this disease. Here, TGFB1 is linked to diabetes mellitus.